What Theriva Biologics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Shallcross Steven A | CEO and CFO | Jun 07 | Open-market buy · P | +14,000 | $0.69 | +$9.7K | 250,000 |
| Shallcross Steven A | CEO and CFO | Jun 06 | Open-market buy · P | +26,000 | $0.63 | +$16.5K | 236,000 |
| Shallcross Steven A | CEO and CFO | Feb 10 | Open-market buy · P | +25,000 | $1.04 | +$26.1K | 210,000 |
| Shallcross Steven A | CEO and CFO | Feb 02 | Open-market buy · P | +25,000 | $0.94 | +$23.5K | 185,000 |
| Shallcross Steven A | CEO and CFO | Jan 25 | Open-market buy · P | +25,000 | $0.87 | +$21.8K | 160,000 |
| Shallcross Steven A | CEO and CFO | Jan 20 | Open-market buy · P | +25,000 | $0.75 | +$18.7K | 135,000 |
| Shallcross Steven A | CEO and CFO | Dec 29 | Open-market buy · P | +100,000 | $0.44 | +$43.7K | 110,000 |
| Shallcross Steven A | CEO and CFO | May 10 | Open-market buy · P | +50,000 | $0.49 | +$24.6K | 100,000 |
| Shallcross Steven A | CEO and CFO | Aug 23 | Open-market buy · P | +50,000 | $0.42 | +$20.8K | 50,000 |
| Kirk Randal J | 10% owner | Apr 03 | Open-market sale · S | −69,161 | $0.65 | −$45K | 165,332 |
| Kirk Randal J | 10% owner | Apr 03 | Open-market sale · S | −26,080 | $0.65 | −$17K | 62,342 |
| Kirk Randal J | 10% owner | Apr 02 | Open-market sale · S | −9,909 | $0.66 | −$6.54K | 234,493 |
| Kirk Randal J | 10% owner | Apr 02 | Open-market sale · S | −3,737 | $0.66 | −$2.47K | 88,422 |
| Kirk Randal J | 10% owner | Apr 01 | Open-market sale · S | −30,265 | $0.67 | −$20.3K | 244,402 |
| Kirk Randal J | 10% owner | Apr 01 | Open-market sale · S | −11,413 | $0.67 | −$7.65K | 92,159 |
| Kraws Jeffrey J | Director | Mar 14 | Exercise / conversion · M | +228,773 | $0.09 | +$20.6K | 228,773 |
| Tarriff Scott | Director | Nov 18 | Grant / award · A | +300,000 | — | — | 300,000 |
| Kirk Randal J | 10% owner | Sep 02 | Open-market buy · P | +937,500 | $3.20 | +$3M | 9,613,268 |
| Wolf Jeffrey Alan | Director | Apr 01 | Exercise / conversion · M | +10,842 | $0.09 | +$976 | 10,842 |
| Ballantyne Charles Evan | Chief Financial Officer | May 22 | Open-market buy · P | +10,000 | $1.35 | +$13.5K | 10,000 |
Loading...
